Lucintel Forecasts The Global Microbiome Therapeutic Market To Reach $1 Billion By 2030

By Author: Lucintel LLC
Total Articles: 4213
Comment this article

According to a market report by Lucintel, the future of the global microbiome therapeutic market looks promising with opportunities in the c. difficile, Crohn's disease, and inflammatory bowel disease, and diabetes markets. The global microbiome therapeutic market is expected to reach an estimated $1 billion by 2030 with a CAGR of 32.4% from 2024 to 2030. The major drivers for this market are rising number of strategic collaborations for microbiome therapeutics for R&D and surge in the prevalence of target disease.
A more than 150–page report is developed to understand Trends, opportunity and forecast in microbiome therapeutic market to 2030 by type (FMT and microbiome drug), application (c. difficile, crohn’s disease, inflammatory bowel disease, diabetes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
In this market, FMT and microbiome drug are the major segments of microbiome therapeutic market by type. Lucintel forecasts that FMT will remain the larger segment over the forecast period due to rising R&D focusing on developments to discover other therapeutic ...
... applications of FMT.
Within this market, c. difficile is expected to witness the highest growth.
Download sample by clicking on microbiome therapeutic market
North America will remain the largest region over the forecast period due to growing target population in the region.
OpenBiome, Seres Therapeutics, Locus Biosciences, 4D Pharma, Enterome, Finch Therapeutics, Intralytix, Microbiotica, Second Genome, and Rebiotix are the major suppliers in the microbiome therapeutic market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
Epoxy Adhesive Market in Canada
Expanded Metal Fence Market in Canada
Flame Retardant Pbt Market in Canada
Galvanized Steel Wire Market in Canada
Lng Carrier Containment Market in Canada